Assisted Reproductive Technology Market Overview
The Global Assisted Reproductive Technology Market is expected to reach a value of USD 28.7 billion in 2023, and it is further anticipated to reach a market value of USD 49.0 billion by 2032 at a CAGR of 6.1%.
Assisted Reproductive Technology (ART) includes different procedures, like ICSI (intracytoplasmic sperm injection), IVF (in vitro fertilization), cryopreservation of embryos or gametes, fertility medications, & more. ART includes employing medical methods to address infertility, defined by the World Health Organization as the inability to conceive naturally after a year without contraception. Both men & women can experience infertility, and when these techniques are utilized to address infertility, they're termed fertility treatments. ART mainly serves to address infertility & reproductive endocrinology issues, with surrogacy arrangements often influenced by these methods.
Recent developments in Assisted Reproductive Technology (ART) market show its explosive growth, especially with regards to IVF services expansion. Australia recently launched an investment initiative of millions that will make fertility treatments more accessible, including subsidies for ART procedures; this effort seeks to address rising infertility issues while simultaneously increasing fertility rates overall.
Growing demand for assisted reproductive technology (ART) services is being driven by social shifts, with an increase in single parents, same-sex couples and individuals choosing ART as an avenue to build families. This trend demonstrates a cultural acceptance of diverse family structures which is driving adoption of these services worldwide - Japan and India being prime examples where demand has skyrocketed.
Technological innovations are expanding opportunities in the ART market. Developments such as non-invasive genetic testing and embryo screening are improving success rates and patient outcomes, while private equity investments like Baring Private Equity's acquisition of Indira IVF by expanding access to treatment in developing regions further propelled market expansion.
Global IVF market witnessed more than two million cycles performed annually, resulting in approximately 300,000. Over 69,000 children were born via IVF in Japan alone during 2021 while India saw its fertility clinic count grow from 150 in 2011 to over 2,500 by 2023.
This growth can be attributed primarily to increasing awareness and acceptance of assisted reproductive technologies.
Australia recently made an investment of USD 42.3 million into artificial reproductive technology (ART), in response to an estimated 1 in 6 Australians facing infertility. Demand for services such as embryo freezing and genetic screening continues to increase with increasing success rates for ART treatments in Australia; similarly 2.3% of births take place via ART treatment here in the U.S.
Assisted Reproductive Technology Market Key Takeaways
- Market Growth: The ART market is expanding due to rising infertility rates, advancements in technology, and increasing awareness.
- Dominant Procedures: In-vitro fertilization (IVF) remains the leading ART procedure, driven by high success rates and technological innovations.
- Rising Demand: Delayed pregnancies, lifestyle changes, and growing acceptance of ART are fueling market demand.
- Technological Advancements: AI, genetic screening, and improved embryo freezing techniques are enhancing ART success rates.
- Regulatory Landscape: Stringent regulations and ethical considerations vary across countries, influencing market dynamics.
- Regional Insights: North America and Europe dominate the market, while Asia-Pacific is witnessing rapid growth due to increasing medical tourism.
- Challenges: High costs, limited insurance coverage, and social stigma in some regions remain key barriers to adoption.
Assisted Reproductive Technology Market Use Cases
- In-Vitro Fertilization (IVF): Helps couples with infertility conceive by fertilizing eggs outside the body and implanting embryos in the uterus.
- Intrauterine Insemination (IUI): Enhances conception chances by placing sperm directly into the uterus during ovulation.
- Egg and Sperm Freezing (Cryopreservation): Preserves reproductive cells for future use, benefiting individuals undergoing medical treatments like chemotherapy.
- Preimplantation Genetic Testing (PGT): Screens embryos for genetic disorders before implantation, ensuring healthier pregnancies.
- Surrogacy Assistance: Enables individuals or couples facing medical issues to have children through gestational carriers.
- Hormone Therapy for Ovulation Induction: Stimulates egg production in women with irregular ovulation to improve fertility treatment success.
- Third-Party Reproduction (Donor Egg/Sperm): Provides reproductive options for individuals with genetic disorders or infertility issues.
Assisted Reproductive Tech Market Dynamic
The growth of the Assisted Reproductive Technology market in the coming years is highly influenced by a growing number of single parents & rise in awareness regarding same-sex marriages & ART options. Further, in 2022, 32 countries legally recognized same-sex marriages, with more nations moving toward similar recognition, as indicated by the Human Rights Campaign (HRC) Foundation. The growth in the prevalence of same-sex marriages is anticipated to drive a notable demand increase for ART techniques, fueling market growth.
However, certain factors could challenge the ART market's progress in the forecasted period, which includes growing medical procedure costs, ethical concerns, the risk of prematurity associated with ART, & a relatively lower success rate. These challenges may create obstacles to the market's growth despite the driving factors, raising concerns about its growth potential.
Assisted Reproductive Tech Market Research Scope and Analysis
By Type
While considering the types of assisted reproductive technology market segments into
In Vitro Fertilization (IVF), artificial insemination & others. IVF will take the lead in global revenue in 2023, which includes frozen donor, fresh donor, fresh non-donor, & frozen non-donor procedures. where the frozen non-donor IVF procedure stands out due to its advantages over other IVF methods, as it is preferred when a woman has healthy eggs but requires ART due to male infertility or fallopian tube issues, this approach's popularity is rising compared to other IVF methods.
Also,
artificial insemination is anticipated to have high growth during the forecast period, which includes categories like intracervical, intrauterine, intravaginal, & intratubal insemination. Mainly employed for minor fertility issues, it's often chosen by same-sex couples or single women. Success rates differ by age, with higher chances for young women, as reported by the Human Fertilization and Embryology Authority (HFEA). In addition, the majority of women undergoing intrauterine insemination achieve pregnancy within their first 6 cycles.
By End User
The global assisted reproductive technology market is categorized by end-users into
fertility clinics, hospitals, and others. The fertility clinics segment takes the lead in 2023, contributing the largest share of the industry's total revenue, which is anticipated to maintain its dominant position throughout the forecast period, growing at a high rate. The driving factors behind its growth include the rise in number of infertility cases, the demand for specialized facilities to conduct ART procedures, & the appeal of cost-effective, specialized, & customized treatments.
In addition, the hospitals are expected to witness significant growth in low- and middle-income countries, mainly in places where establishing dedicated fertility clinics presents infrastructure challenges. In such regions, multispecialty hospitals have emerged as the major and most accessible choice for infertility treatment in driving the growth of the market.
The Assisted Reproductive Technology Market Report is segmented on the basis of the following
By Type
- In-Virto Fertilization (IVF)
- Artificial Insemination
- Others
By End User
- Hospitals
- Fertility Clinics
- Others
How Does Artificial Intelligence Contribute To Improve Assisted Reproductive Technology Market ?
- Embryo Selection & Quality Assessment: AI-powered imaging and algorithms analyze embryo development, improving selection accuracy and IVF success rates.
- Predictive Analytics for Treatment Success: AI evaluates patient data to predict ART success probabilities, aiding personalized treatment plans.
- Sperm & Egg Quality Analysis: AI-driven tools assess sperm motility, morphology, and egg viability to enhance fertilization outcomes.
- Automated IVF Laboratory Processes: Robotics and AI streamline lab procedures like embryo culture and cryopreservation, reducing human error.
- Personalized Hormone Therapy Optimization: AI analyzes hormonal responses to customize stimulation protocols, improving ovulation outcomes.
- Data-Driven Patient Counseling: AI assists clinicians by providing evidence-based insights, helping patients make informed fertility decisions.
- Regulatory Compliance & Documentation: AI automates record-keeping and compliance tracking, ensuring adherence to ART regulations.
Assisted Reproductive Tech Market Regional Analysis
Europe stands out as the region dominating the assisted reproductive technology (ART) market in
2023, contributing about 38.0% of the total revenue, which is linked to growth in infertility rates, a rise in awareness about fertility treatments, technological progress, & assistance from government programs. In addition, as per the European Society of Human Reproduction & Embryology, there are around
25 million individuals in the European Union grappling with infertility, the highest across the globe.
Moreover, North America is anticipated for significant growth in the ART market, mainly driven by positive patient outcomes from these treatments. In addition, technological advancements & increased research efforts in the field of ART are anticipated to further stimulate market expansion in the Asia Pacific region as well.
By Region
North America
Europe
- Germany
- The U.K.
- France
- Italy
- Russia
- Spain
- Benelux
- Nordic
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- ANZ
- ASEAN
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Egypt
- Rest of MEA
Assisted Reproductive Tech Market Competitive Landscape
In the market of Assisted Reproductive Technology (ART), competition experienced by the players is at a moderate level, marked by the involvement of key industry players, as they have established positions & contributions, shaping the landscape of ART services, driving innovation & quality in this specialized sector. This dynamic environment encourages advancements & choices for individuals seeking fertility solutions.
In February 2023, Bumrungrad International Hospital introduced its Fertility Center & IVF Clinic, providing complete reproductive services, which provides a complete range of care, from initial consultations to advanced Assisted Reproductive Technology (ART) procedures. It's a valuable resource for families looking for support on their journey to parenthood, offering a one-stop solution for all their reproductive needs.
Some of the prominent players in the global Assisted Reproductive Technology Market are:
- Ferring B.V.
- Fujifilm Irvine Scientific
- CooperSurgical Inc
- Vitrolife
- Microm Ltd
- Bloom IVF Centre
- Laboratoire CCD
- OvaScience Inc
- Esco Medical
- Cryolab Ltd
- Other Key Players
COVID-19 Pandemic & Recession: Impact on the Global Assisted Reproductive Technology Market
The COVID-19 pandemic & the following economic recession had a diverse impact on the global Assisted Reproductive Technology (ART) market. While at the start disruptions like clinic closures & postponed treatments impacted the industry, there was a significant growth in demand as more individuals & couples turned to ART to fulfill their family planning goals during the lockdowns. Economic uncertainties led some to halt treatments, but overall, the ART market experienced resilience & adaptability, with ongoing growth driven by developing technology & evolving patient needs.
Assisted Reproductive Technology Market Recent Developments
- Private Equity Investments and Industry Consolidation: Private equity firms are actively investing in the fertility sector, acquiring fragmented clinics and chains to capitalize on the industry's resilience and consistent demand. Notable acquisitions include CARE Fertility by Nordic Capital and GeneraLife by KKR. This consolidation aims to enhance service quality and expand market reach.
- Regulatory and Legal Challenges: Recent legal developments, such as the Alabama Supreme Court's decision in February 2024 granting legal rights to frozen embryos, have introduced complexities in ART practices. This ruling led some fertility clinics to temporarily suspend services to navigate potential legal risks, highlighting the evolving regulatory landscape's impact on ART accessibility.
- Technological Advancements and Innovations: The ART market continues to benefit from technological innovations, including the integration of artificial intelligence in embryo selection and genetic screening. These advancements aim to improve success rates and patient outcomes, reflecting the industry's commitment to adopting cutting-edge solutions.
Assisted Reproductive Technology Market Report Details
| Report Characteristics |
| Market Size (2023) |
USD 28.7 Bn |
| Forecast Value (2032) |
USD 49.0 Bn |
| CAGR (2023-2032) |
6.1% |
| Historical Data |
2017 - 2022 |
| Forecast Data |
2023 - 2032 |
| Base Year |
2022 |
| Estimate Year |
2023 |
| Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
| Segments Covered |
By Type (In-Virto Fertilization (IVF), Artificial
Insemination, and Others), By Others (Hospitals,
Fertility Clinics, and Others) |
| Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
| Prominent Players |
Ferring B.V., Fujifilm Irvine Scientific, CooperSurgical
Inc, Vitrolife, Microm Ltd, Bloom IVF Centre,
Laboratoire CCD, OvaScience Inc, Esco Medical,
Cryolab Ltd, and Other Key Players |
| Purchase Options |
We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users), and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively. |
Frequently Asked Questions
The Global Assisted Reproductive Technology Market is estimated to reach USD 28.7 billion in 2023,
which is further expected to reach USD 49.0 billion by 2032.
Europe dominates the Global Assisted Reproductive Technology Market with a share of 38.0% in 2023.
Some of the major key players in the Global Assisted Reproductive Technology Market are Ferring B.V.,
Microm Ltd, Vitrolife, and many others.
The market is growing at a CAGR of 6.1 percent over the forecasted period.